----

| Nevada                          | 84-1724410          |
|---------------------------------|---------------------|
| (State or other jurisdiction of | (I.R.S. Employer    |
| incorporation or organization)  | Identification No.) |

----

|                                                            | PageNumber |
|-----------------------------------------------------------------|------------|
|                                                            |       |
|      Balance Sheets                    | 3          |
|                                                            |       |
|      Statements of Operations          | 4          |
|                                                            |       |
|      Statement of Stockholder's Equity | 5          |
|                                                            |       |
|      Statements of Cash Flows          | 6          |
|                                                            |       |
|      Notes to the Financial Statements | 7          |

----

| ENHANCE SKIN PRODUCTS INC.                 |                                       |
|--------------------------------------------|--------------------------------------------|
| formerly Zeezoo Software Corp.             |                                       |
|                                       |                                       |   |   |   |   |   |   |
| CONSOLIDATED BALANCE SHEETS                |                                       |
|                                       |                                       |   |   |   |   |   |   |
|                                       |                                       |   |   |   |   |   |   |
|                                       |                                       |   | July 31 |   |   | April 30 |   |
|                                       |                                       |   | 2009 |   |   | 2009 |   |
|                                       |                                       |   |   |   |   |   |   |
| ASSETS                                     |                                       |   |   |   |   |   |
| Current                                    |                                       |   |   |   |   |   |
| Cash                                       |                                       | $ | 147,568 |   |   | $ | 361,606 |   |
| Accounts receivable                        |                                       |   | 13,549 |   |   |   | 8,609 |   |
| Prepaids & deposits                    |                                       |   | 7,507 |   |   |   | 19,228 |   |
| Inventory                                  |                                       |   | 79,809 |   |   |   | 43,613 |   |
|                                       |                                       |   |   |   |   |   |   |   |   |
|                                       | Total current assets                       |   |   | 248,433 |   |   |   | 433,056 |   |
|                                       |                                       |   |   |   |   |   |   |   |   |
| Other assets                               |                                       |   |   |   |   |   |   |   |
| Patent applications                        |                                       |   | 49,257 |   |   |   | 43,166 |   |
| Trademarks                                 |                                       |   | 44,115 |   |   |   | 44,115 |   |
|                                       |                                       |   |   |   |   |   |   |   |   |
|                                       | Total other assets                         |   |   | 93,372 |   |   |   | 87,281 |   |
|                                       |                                       |   |   |   |   |   |   |   |   |
| Total assets                               |                                       | $ | 341,805 |   |   | $ | 520,337 |   |
|                                       |                                       |   |   |   |   |   |   |   |   |
|                                       |                                       |   |   |   |   |   |   |   |   |
| LIABILITIES AND STOCKHOLDER'S EQUITY       |                                       |   |   |   |   |   |   |   |
| Current liabilities                        |                                       |   |   |   |   |   |   |   |
| Accounts payable and accrued liabilities   |                                       | $ | 18,369 |   |   | $ | 16,504 |   |
| Accounts payable to related party          |                                       |   | 284 |   |   |   | 259 |   |
|                                       |                                       |   |   |   |   |   |   |   |   |
|                                       | Total current liabilities                  |   |   | 18,653 |   |   |   | 16,763 |   |
|                                       |                                       |   |   |   |   |   |   |   |   |
|                                       |                                       |   |   |   |   |   |   |   |   |
| Stockholders equity                        |                                       |   |   |   |   |   |   |   |
| Authorized:                                |                                       |   |   |   |   |   |   |   |   |
|                                       | 100,000,000 common shares per value $0.001 |   |   |   |   |   |   |   |   |
| Issued and outstanding 49,250,000 as of    |                                       |   |   |   |   |   |   |   |
|                                       | July 31, 2009 and April 30, 2009           |   |   | 49,250 |   |   |   | 49,250 |   |
| Additional paid-in capital                 |                                       |   | 1,337,055 |   |   |   | 1,337,055 |   |
| Translation adjustment                     |                                       |   | 12,150 |   |   |   | 10,297 |   |
| Retained deficit                           |                                       |   | (1,075,303 | ) |   |   | (893,028 | ) |
|                                       |                                       |   |   |   |   |   |   |   |   |
| Total stockholders' equity                 |                                       |   | 323,152 |   |   |   | 503,574 |   |
|                                       |                                       |   |   |   |   |   |   |   |   |
| Total liabilities and stockholders' equity |                                       | $ | 341,805 |   |   | $ | 520,337 |   |

----

| ENHANCE SKIN PRODUCTS INC.                                   |   |
|--------------------------------------------------------------|--------|
| formerly Zeezoo Software Corp.                               |   |
|                                                         |   |
| CONSOLIDATED STATEMENTS OF OPERATIONS                        |   |
| For the three months ending July 31, 2009, and July 31, 2008 |   |
|                                                         |   |   |   |   |   |   |
|                                                         |   | July 31 |   |   | July 31 |   |
|                                                         |   | 2009 |   |   | 2008 |   |
|                                                         |   |   |   |   |   |   |
| EXPENSES                                                     |   |   |   |   |   |   |
| Operating expenses                                           |   |   |   |   |   |   |
| General & administrative                                 |   | $ | 128,569 |   |   | $ | 4,546 |   |
| Professional fees                                            |   |   | 3,784 |   |   |   | - |   |
| Marketing                                                    |   |   | 50,204 |   |   |   | - |   |
|                                                         |   |   |   |   |   |   |   |   |
|                                                         |   |   | 182,557 |   |   |   | 4,546 |   |
|                                                         |   |   |   |   |   |   |   |   |
| Net loss before other items                                  |   |   | (182,557 | ) |   |   | (4,546 | ) |
|                                                         |   |   |   |   |   |   |   |   |
| Other items                                                  |   |   |   |   |   |   |   |   |
| Interest on long term debt                                   |   |   | - |   |   |   | 628 |   |
| Interest income                                              |   |   | (282 | ) |   |   | - |   |
|                                                         |   |   |   |   |   |   |   |   |
| Net loss before income taxes                                 |   |   | (182,275 | ) |   |   | (5,174 | ) |
|                                                         |   |   |   |   |   |   |   |   |
| Provision for income taxes                                   |   |   | - |   |   |   | - |   |
|                                                         |   |   |   |   |   |   |   |   |
| Net loss                                                     |   | $ | (182,275 | ) |   | $ | (5,174 | ) |
|                                                         |   |   |   |   |   |   |   |   |
| Basic and diluted loss per common share                      |   | $ | (0.00 | ) |   | $ | (517.40 | ) |
|                                                         |   |   |   |   |   |   |   |   |
| Weighted average number of common                            |   |   |   |   |   |   |   |   |
| shares outstanding                                           |   |   | 49,250,000 |   |   |   | 10 |   |

----

| ENHANCE SKIN PRODUCTS INC.                                                   |   |
|------------------------------------------------------------------------------|--------|
| formerly Zeezoo Software Corp.                                               |   |
|                                                                         |   |
| CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY                               |   |
| For the three months ending July 31, 2009 and the year ending April 30, 2009 |   |
|                                                                         |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|                                                                         |   |   |   |   |   |   |   | Additional |   |   |   |   |   |   |   |   | Total |   |
|                                                                         |   | Common Stock |   |   | paid in |   |   | Translation |   |   | Retained |   |   | Stockholders |   |
|                                                                         |   | Shares |   |   | Amount |   |   | Capital |   |   | Adjustment |   |   | Deficit |   |   | Equity |   |
|                                                                         |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Balance April 30, 2008                                                       |   |   | 10 |   |   |   | 90 |   |   |   | 222,687 |   |   |   | (3,741 | ) |   |   | (207,809 | ) |   |   | 11,227 |   |
|                                                                         |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Asset Purchase Agreement executed August 14, 2008                            |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|     Shares assumed                                       |   |   | 20,250,000 |   |   |   | 20,250 |   |   |   | (20,250 | ) |   |   |   |   |   |   |   |   |   |   | - |   |
|     Shares issued                                        |   |   | 27,500,000 |   |   |   | 27,500 |   |   |   | (27,500 | ) |   |   |   |   |   |   |   |   |   |   | - |   |
| Shares cancelled                                                             |   |   | (10 | ) |   |   | (90 | ) |   |   | 90 |   |   |   |   |   |   |   |   |   |   |   | - |   |
| Private placement closed August 14, 2008 @ $1.00                        |   |   | 1,500,000 |   |   |   | 1,500 |   |   |   | 1,153,900 |   |   |   |   |   |   |   |   |   |   |   | 1,155,400 |   |
| Contribution to APIC                                                         |   |   |   |   |   |   |   |   |   |   | 10,749 |   |   |   |   |   |   |   |   |   |   |   | 10,749 |   |
| Net liabilities acquired from Zeezoo                                         |   |   |   |   |   |   |   | (2,621 | ) |   |   |   |   |   |   |   |   |   |   | (2,621 | ) |
| Increase in translation adjustment                                           |   |   |   |   |   |   |   |   |   |   |   | 14,038 |   |   |   |   |   |   |   | 14,038 |   |
| Net loss for the  period                                           |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   | (685,219 | ) |   |   | (685,219 | ) |
|                                                                         |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Balance April 30, 2009                                                       |   |   | 49,250,000 |   |   | $ | 49,250 |   |   | $ | 1,337,055 |   |   | $ | 10,297 |   |   | $ | (893,028 | ) |   | $ | 503,574 |   |
|                                                                         |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Increase in translation adjustment                                           |   |   |   |   |   |   |   |   |   |   |   | 1,853 |   |   |   |   |   |   |   | 1,853 |   |
| Net loss for the  period                                           |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   | (182,275 | ) |   |   | (182,275 | ) |
|                                                                         |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Balance July 31, 2009                                                        |   |   | 49,250,000 |   |   | $ | 49,250 |   |   | $ | 1,337,055 |   |   | $ | 12,150 |   |   | $ | (1,075,303 | ) |   | $ | 323,152 |   |

----

| ENHANCE SKIN PRODUCTS INC.                                   |   |
|--------------------------------------------------------------|--------|
| formerly Zeezoo Software Corp.                               |   |
|                                                         |   |
| CONSOLIDATED STATEMENTS OF CASH FLOWS                        |   |
| For the three months ending July 31, 2009, and July 31, 2008 |   |
|                                                         |   |   |   |   |   |   |
|                                                         |   | July 31 |   |   | July 31 |   |
|                                                         |   | 2009 |   |   | 2008 |   |
|                                                         |   |   |   |   |   |   |
| CASH FLOWS FROM OPERATING ACTIVITIES                         |   |   |   |   |   |   |
| Net loss for the period                                      |   | $ | (182,275 | ) |   | $ | (5,174 | ) |
| Changes in operating assets and liabilities:                 |   |   |   |   |   |   |   |   |
| Accounts receivable                                          |   |   | (4,940 | ) |   |   | 776 |   |
| Prepaids & deposits                                      |   |   | 11,721 |   |   |   | 1,339 |   |
| Inventory                                                    |   |   | (36,196 | ) |   |   | - |   |
| Accounts payable and accrued liabilities                     |   |   | 1,865 |   |   |   | - |   |
| Accounts payable to related party                            |   |   | 25 |   |   |   | - |   |
|                                                         |   |   |   |   |   |   |   |   |
| Cash flows from operating activities                         |   |   | (209,800 | ) |   |   | (3,059 | ) |
|                                                         |   |   |   |   |   |   |   |   |
|                                                         |   |   |   |   |   |   |   |   |
| CASH FLOWS FROM INVESTING ACTIVITIES                         |   |   |   |   |   |   |   |   |
| Patent applications                                          |   |   | (6,091 | ) |   |   | 63 |   |
| Trademarks                                                   |   |   | - |   |   |   | 2,280 |   |
|                                                         |   |   |   |   |   |   |   |   |
| Cash flows from investing activities                         |   |   | (6,091 | ) |   |   | 2,343 |   |
|                                                         |   |   |   |   |   |   |   |   |
|                                                         |   |   |   |   |   |   |   |   |
| CASH FLOWS FROM FINANCING ACTIVITIES                         |   |   |   |   |   |   |   |   |
| Increase in additional paid in Capital                       |   |   | - |   |   |   | 10,749 |   |
| Payment of loans                                             |   |   | - |   |   |   | (6,746 | ) |
|                                                         |   |   |   |   |   |   |   |   |
| Cash flows from financing activities                         |   |   | - |   |   |   | 4,003 |   |
|                                                         |   |   |   |   |   |   |   |   |
|                                                         |   |   |   |   |   |   |   |   |
| NET INCREASE (DECREASE) IN CASH                              |   |   | (215,891 | ) |   |   | 3,287 |   |
| Effect of foreign currency translation adjustments           |   |   | 1,853 |   |   |   | (199 | ) |
|                                                         |   |   |   |   |   |   |   |   |
| Cash, beginning of the period                                |   |   | 361,606 |   |   |   | (3,088 | ) |
|                                                         |   |   |   |   |   |   |   |   |
| Cash, end of the period                                      |   | $ | 147,568 |   |   | $ | - |   |
|                                                         |   |   |   |   |   |   |   |   |
| Supplemental disclosure with respect to cash flows:          |   |   |   |   |   |   |   |   |
| Cash paid for income taxes                                   |   | $ | - |   |   | $ | - |   |
| Cash paid for interest                                       |   | $ | - |   |   | $ | 628 |   |

----

NOTES 

----

| ▪     | a significant decrease in the market price of the asset; |
|---------------------------------|----------------------------------------------------------|

| ▪     | a significant change in the extent or manner in which the asset is being used; |
|---------------------------------|--------------------------------------------------------------------------------|

| ▪     | a significant change in the business climate that could affect the value of the asset; |
|---------------------------------|----------------------------------------------------------------------------------------|

| ▪     | a current period loss combined with projection of continuing loss associated with use of the asset; |
|---------------------------------|-----------------------------------------------------------------------------------------------------|

| ▪     | a current expectation that, more likely than not, the asset will be sold or otherwise disposed of before the end of its previously estimated useful life. |
|---------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|   | • | Management is currently manufacturing products to generate sales. There can be no assurances, however, that management’s expectations of future sales will be realized. |
|--------|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|   |           |   |            | Warrants     |    |
|--------|----------------|--------|-----------------|--------------|---------|
|   |           |   |            | Issued  |    | Outstanding |   |
|   | July 31,       |   | July 31,        |         |
|   | Exercise Price |   | Expiration Date |         | 2009    |   | 2009 |   |
|   | 1.40           |   | August 14, 2010 |         | 750,000 |   | 750,000 |   |

----

|           |   | July 31 |   |   | April 30 |   |
|----------------|--------|---------|--------|--------|----------|--------|
|           |   | 2009    |   |   | 2009     |   |
| Finished Goods |   |    | 36,011 |   |     |   | 0 |   |
| Raw materials  |   |    | 43,798 |   |     |   | 43,613 |   |
|           |   |    | 79,809 |   |     |   | 43,613 |   |

| Fiscal |   | Lease     |   |   |   |   |
|--------|--------|-----------|--------|--------|--------|--------|
| Year   |   | Agreement |   |   | Total  |   |
| 2010   |   | $         | 7,380  |   |   | $      | 7,380 |   |
| 2011   |   |      | 9,840  |   |   |   | 9,840 |   |
| 2012   |   |      | 4,920  |   |   |   | 4,920 |   |
| 2013   |   |      | 0      |   |   |   | 0 |   |
| 2014   |   |      | 0      |   |   |   | 0 |   |
| Total  |   | $         | 22,140 |   |   | $      | 22,140 |   |

----

|                                   | First quarter ended July 31,2009 |        |
|----------------------------------------|----------------------------------|-------------|
|                                   |                             | Jul 31 2008 |   |   | Jul 31 2009 |   |   | $ Change |   |   | % Change |   |
| Total Sales                            |                             | $           | - |   |   | $ | - |   |   | $ | - |   |   |   | n/a |   |
| Cost of goods sold                     |                             |        | - |   |   |   | - |   |   |   | - |   |   |   | n/a |   |
| Gross profit                           |                             |        | - |   |   |   | - |   |   |   | - |   |   |   | n/a |   |
| Operating expenses                     |                             |        | 4,546 |   |   |   | 182,557 |   |   |   | 178,011 |   |   |   | 3916 |  % |
| Net loss befor other items             |                             |        | (4,546 | ) |   |   | (182,557 | ) |   |   | (178,011 | ) |   |   | 3916 |  % |
| Other items                            |                             |        |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|   Interest on long term debt |                             |        | 628 |   |   |   | - |   |   |   | (628 | ) |   |   | (100 | )% |
|   Interest income            |                             |        | - |   |   |   | (282 | ) |   |   | (282 | ) |   |   | n/a |   |
| Net loss                               |                             | $           | (5,174 | ) |   | $ | (182,275 | ) |   | $ | (177,101 | ) |   |   | 3423 |  % |
|                                   |                             |        |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Total assets                           |                             |        | 520,337 |   |   |   | 341,805 |   |   |   | (178,532 | ) |   |   | (34 | )% |

----

----

| ExhibitNumber |   | Description                                                                    |
|---------------|--------|--------------------------------------------------------------------------------|
|          |   |                                                                           |
| 31.1          |   | Certification  of CEO Pursuant TO 18 U.S.C. § 1350, Section 302 |
| 31.2          |   | Certification  of CFO Pursuant to 18 U.S.C. § 1350, Section 302 |
| 32.1          |   | Certification Pursuant to 18 U.S.C. § 1350, Section 906                   |
| 32.2          |   | Certification Pursuant to 18 U.S.C. § 1350, Section 906                   |

----

|                           | ENHANCE SKIN PRODUCTS INC. |                                                           |
|--------------------------------|----------------------------|----------------------------------------------------------------|
|                           |                       |                                                           |   |
|                           |                       |                                                           |   |
| Date:  September 21, 2009 | By:                        | /s/ Dr. Samuel S. Asculai                                 |   |
|                           |                       | Name:  Dr. Samuel S. Asculai                              |   |
|                           |                       | Title:    President/CEO, Principal Executive Officer |   |

| Date:  September 21, 2009 | By:    | /s/ Brian Lukian                                                              |   |
|--------------------------------|--------|------------------------------------------------------------------------------------|--------|
|                           |   | Name:  Brian Lukian                                                      |   |
|                           |   | Title:    Chief Financial Officer, Principal Financial Officer |   |

----